BIIB vs TGL · P/E 21, rev $9.89B vs rev $2.3M
Biogen Inc (BIIB) versus Treasure Global Inc. (TGL) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Treasure Global Inc. (TGL) is a software - application company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported TGL revenue for 2025-06-30 was $2.3M. Net income was -$23.4M. Revenue was down 89.4% from 2024-06-30 to 2025-06-30. TGL currently screens at market cap $7.0M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. TGL currently screens at market cap $7.0M.
Not investment advice. Open the BIIB and TGL stock pages for the full models.
Not investment advice.